TipRanks
Advertisement
Advertisement

DE:IDD Stock Latest News

Innate Pharma to deliver H1 2026 business update via investor webcast
Company AnnouncementsInnate Pharma to deliver H1 2026 business update via investor webcast
6d ago
Innate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference
PremiumCompany Announcements
Innate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference
14d ago
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
PremiumCompany Announcements
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
14d ago
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
PremiumCompany Announcements
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
27d ago
6K
Innate Pharma price target raised to $9 from $8 at BTIG
PremiumThe Fly
Innate Pharma price target raised to $9 from $8 at BTIG
30d ago
IPHA
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
PremiumCompany AnnouncementsInnate Pharma Schedules Investor Call as Oncology Pipeline Advances
1M ago
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
Premium
Company Announcements
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
1M ago
Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway
Premium
Company Announcements
Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway
1M ago
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
PremiumThe Fly
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
1M ago
IPHA
Innate Pharma upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Innate Pharma upgraded to Outperform from Market Perform at Leerink
1M ago
IPHA
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
PremiumThe Fly
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
1M ago
IPHA
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
PremiumThe Fly
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
1M ago
IPHA
Innate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
PremiumThe FlyInnate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
1M ago
IPHA
Innate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO
Premium
Company Announcements
Innate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO
1M ago
Innate Pharma CMO to Spotlight Cancer Pipeline at BTIG Bladder Cancer Panel
Premium
Company Announcements
Innate Pharma CMO to Spotlight Cancer Pipeline at BTIG Bladder Cancer Panel
2M ago
Innate Pharma Completes Phase 1 Dose Escalation Enrollment for Nectin-4 ADC IPH4502
PremiumCompany Announcements
Innate Pharma Completes Phase 1 Dose Escalation Enrollment for Nectin-4 ADC IPH4502
2M ago
6K
Innate Pharma completes enrollment in dose escalation of IPH4502 study
PremiumThe Fly
Innate Pharma completes enrollment in dose escalation of IPH4502 study
2M ago
IPHA
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
PremiumCompany Announcements
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
4M ago
6K
Innate Pharma to Court Investors at Jefferies Global Healthcare Conference 2026
PremiumCompany Announcements
Innate Pharma to Court Investors at Jefferies Global Healthcare Conference 2026
4M ago
6K
Innate Pharma: Buy Rating Reaffirmed on Pipeline Momentum and De‑Risking Catalysts; $8 Price Target Unchanged
PremiumRatingsInnate Pharma: Buy Rating Reaffirmed on Pipeline Momentum and De‑Risking Catalysts; $8 Price Target Unchanged
4M ago
IPHA
Innate Pharma Posts Q1 2026 Results as Key Oncology Trials Advance and Cash Runway Tightens
Premium
Company Announcements
Innate Pharma Posts Q1 2026 Results as Key Oncology Trials Advance and Cash Runway Tightens
4M ago
6K
Innate Pharma Updates Share Capital and Voting Rights as of April 16, 2026
Premium
Company Announcements
Innate Pharma Updates Share Capital and Voting Rights as of April 16, 2026
4M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >